Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine
DOI:
https://doi.org/10.1016/j.clinsp.2022.100007Downloads
Download data is not yet available.
Downloads
Published
2022-02-02
Issue
Section
Comments
How to Cite
Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine. (2022). Clinics, 77, 100007. https://doi.org/10.1016/j.clinsp.2022.100007